Bristol-Myers Squibb (BMY)’s Cellares Exit Raises Questions Over Breyanzi Growth

Bristol-Myers Squibb Company (NYSE:BMY) has ended its partnership with cell-therapy manufacturer Cellares after determining that Cellares’ Cell Shuttle platform could not meet the requirements needed ...
Nasdaq

Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance

INCHEON, South Korea, Sept. 17, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced today a new agreement with Bristol Myers Squibb (NYSE: BMY) for large-scale manufacturing of a Bristol ...
Nasdaq

Oxford Biomedica Signs Multi-Year Commercial Supply Deal With Bristol Myers Squibb

(RTTNews) - Oxford Biomedica plc (OXB.L), a cell and gene therapy contract development and manufacturing organization, on Tuesday said it has signed a new multi-year commercial supply agreement with ...